Biomerica (NASDAQ:BMRA) Share Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Biomerica, Inc. (NASDAQ:BMRAGet Free Report) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.00 and traded as low as $3.13. Biomerica shares last traded at $3.20, with a volume of 59,163 shares.

Biomerica Stock Down 3.6%

The business has a fifty day simple moving average of $3.57 and a 200-day simple moving average of $4.01. The firm has a market cap of $8.15 million, a P/E ratio of -9.41 and a beta of 0.34.

Biomerica (NASDAQ:BMRAGet Free Report) last posted its quarterly earnings data on Monday, April 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. The firm had revenue of $1.12 million during the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Hedge Funds Weigh In On Biomerica

An institutional investor recently bought a new position in Biomerica stock. Bulltick Wealth Management LLC acquired a new position in Biomerica, Inc. (NASDAQ:BMRAFree Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 137,149 shares of the company’s stock, valued at approximately $78,000. Bulltick Wealth Management LLC owned approximately 5.39% of Biomerica as of its most recent filing with the Securities and Exchange Commission. 22.28% of the stock is owned by institutional investors and hedge funds.

Biomerica Company Profile

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Featured Articles

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.